High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A. Nacev(University of Pittsburgh), Sandra P. D’Angelo(Memorial Sloan Kettering Cancer Center), Viswatej Avutu(Memorial Sloan Kettering Cancer Center), Ping Chi(Memorial Sloan Kettering Cancer Center), Travis E. Adamson(Memorial Sloan Kettering Cancer Center), Lauren B. Banks(Memorial Sloan Kettering Cancer Center), William D. Tap(Memorial Sloan Kettering Cancer Center), Mrinal M. Gounder(Memorial Sloan Kettering Cancer Center), Mark T.A. Donoghue(Memorial Sloan Kettering Cancer Center), Jason E. Chan(Memorial Sloan Kettering Cancer Center), Mark A. Dickson(Memorial Sloan Kettering Cancer Center), Evan Rosenbaum(Memorial Sloan Kettering Cancer Center), Martina Bradić(New York University), Sujana Movva(Memorial Sloan Kettering Cancer Center), Robert G. Maki(Memorial Sloan Kettering Cancer Center), Samuel Singer(Memorial Sloan Kettering Cancer Center), Ciara M. Kelly(Memorial Sloan Kettering Cancer Center), Cristina R. Antonescu(Memorial Sloan Kettering Cancer Center), Hyung Jun Woo(Memorial Sloan Kettering Cancer Center), Emily K. Slotkin(Memorial Sloan Kettering Cancer Center), Mary Lou Keohan(Memorial Sloan Kettering Cancer Center), Allison L. Richards(Memorial Sloan Kettering Cancer Center)
Cited by 1
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k